Mycetoma (Madura Foot)

Mycetoma, commonly known as Madura foot, is a chronic, scarring infection of the dermis, subcutaneous tissue and bone. It is defined by a classic clinical triad: painless swelling of granulation tissue, multiple fibrotic draining sinuses, and discharge containing fungal or bacterial grains.

Microbiologically, mycetoma has two entirely different groups of causes:

  • Eumycetoma (maduromycosis): true fungal mycetoma caused by structurally complex filamentous fungi.
  • Actinomycetoma: mycetoma caused by actinomycetes (filamentous bacteria).

Telling these two groups apart is decisive for the outlook and for saving the limb, because their treatments are completely opposite. At Haute-Derma, our approach to Madura foot combines grain analysis, histopathology with special stains and advanced imaging, with the goal of preserving as much mobility and function as possible.

Pathogenesis and Route of Infection

Entry Route and Granulation Tissue Growth

  • Direct inoculation through injury: the organisms enter the skin through small wounds, wood splinters or thorn pricks, or in farmers who habitually walk barefoot on humus-rich soil.
  • Grain formation: once in the subcutaneous tissue, the organism secretes an extracellular matrix that encases clusters of filaments, forming hard grains. This protects it from phagocytosis by the immune system and from penetration by antifungal drugs.
  • Deep invasion and tissue destruction: the infection does not spread through the lymphatics but advances slowly into deeper tissue, destroying fascial planes, muscle and tendon, and eventually invading bone to cause osteomyelitis, bone loss and complete deformity of the foot.

Microbiological Types and Grain Characteristics

True Fungal Mycetoma (Eumycetoma / Maduromycosis)

Accounts for about 40%–50% of mycetoma cases worldwide.

  • Common causative species: Madurella mycetomatis (the most common), Trematosphaeria grisea, Scedosporium apiospermum and Aspergillus spp.
  • Grain features:
    • Black grains: usually Madurella mycetomatis (0.5–2 mm, hard, crumbling like charcoal).
    • White or pale yellow grains: usually Scedosporium apiospermum or Acremonium spp.

Bacterial Mycetoma (Actinomycetoma)

  • Common causative species: Nocardia brasiliensis, Actinomadura madurae, Actinomadura pelletieri and Streptomyces somaliensis.
  • Grain features:
    • Red grains: characteristic of Actinomadura pelletieri.
    • Pink or ivory-white grains: usually Actinomadura madurae or Nocardia.

Comparison of Eumycetoma and Actinomycetoma

FeatureTrue Fungal Mycetoma (Eumycetoma)Bacterial Mycetoma (Actinomycetoma)
Type of organismTrue fungi (eukaryotes)Actinomycetes / filamentous bacteria (prokaryotes)
Rate of progressionVery slow (years to decades)Faster, with more marked inflammation
Grain colorBlack or white/yellowRed, yellow, pink or white
Filament width under the microscopeBroad (2–6 µm), septate fungal hyphaeVery fine bacterial filaments (under 1 µm)
Ziehl-Neelsen / Gram stainZiehl-Neelsen negative, Gram (-)Usually Gram (+); Nocardia partially acid-fast
X-ray / MRI of boneLarge, well-defined lytic cavitiesDiffuse lytic lesions with rapid bone destruction
Response to medical treatmentSlow; surgical debridement usually neededVery good response to combination antibiotics

Standard Diagnostic Workup at Haute-Derma

Direct Grain Examination: pus is collected from the sinuses, or a subcutaneous abscess is gently expressed with a needle. The color, size and hardness of the grains are examined with the naked eye and under the microscope:

  • Crushing the grain in 10% KOH: shows broad, septate hyphae with swollen cells at the tips (eumycetoma).
  • Gram and Ziehl-Neelsen stains: identify fine actinomycete filaments and acid-fastness (actinomycetoma).

Skin and Subcutaneous Biopsy: the biopsy takes the full edge of a sinus tract, including the deep granulation tissue.

  • H&E stain: shows granulomas with central necrosis containing grains, surrounded by neutrophils, plasma cells, macrophages and a fibrous capsule.
  • PAS and GMS stains: highlight the hyphal walls in magenta or black within eumycetoma grains.

Imaging to Assess Depth of Invasion (X-Ray and MRI):

  • X-ray of the limb: assesses periosteal reaction, osteopenia and lytic cavities (geodes).
  • MRI: the "dot-in-circle" sign: a characteristic finding on T2-weighted images of round high-signal areas (inflamed granulation tissue) with a central low-signal dot (the grain), which helps define the exact extent of disease before surgery.

Multimodal Treatment at Haute-Derma

Medical Treatment of True Fungal Mycetoma (Eumycetoma)

Because the grains are surrounded by very thick fibrous tissue, oral antifungals must be given at high doses for a long time:

  • Itraconazole (first-line therapy):
    • Dose: 200 mg twice daily (400 mg/day), taken right after meals.
    • Duration: 6–12 months before surgery is considered, then continued for 6 months after surgery.
  • Voriconazole / posaconazole: used when the infection is resistant to or does not respond to itraconazole (voriconazole 200 mg twice daily).

Limb-Sparing Surgical Treatment

  • Conservative debulking surgery: surgery is not done first while the mycetoma is still very large. Patients receive itraconazole for at least 6 months to shrink the lesion and create a clear fibrous boundary. The surgeon then removes the entire mass while preserving as much healthy bone and tendon as possible.
  • Amputation: considered only as a last resort when the disease has completely destroyed the bones and joints of the foot, causing disability, or when overwhelming infection threatens life.

Frequently Asked Questions (FAQs)

Experiencing similar symptoms?

Our Haute-Derma specialists are ready to provide expert consultation on Mycetoma (Madura Foot) — from accurate diagnosis to the most suitable treatment plan for you.

Same-day appointments · Confidential · Minimal wait time

Nhắn tin cho phòng khám

Để lại lời nhắn, tư vấn viên sẽ gọi lại cho bạn trong giờ làm việc. Kênh này không dùng cho tình trạng khẩn cấp: nếu có dấu hiệu nguy hiểm, hãy gọi 115.

Gọi 0329 279 889